International Journal of Cardiology
Volume 152, Issue 2 , Pages 218-224 , 20 October 2011

Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta

  • Hua Li

      Affiliations

    • Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, PR China
    • ,
  • Hongliang Li

      Affiliations

    • Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, PR China
    • ,
  • Yige Bao

      Affiliations

    • West China Medical School, Sichuan University, Chengdu City, Sichuan Province, PR China
    • ,
  • Xiangxun Zhang

      Affiliations

    • Lab. of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, PR China
    • ,
  • Yerong Yu

      Affiliations

    • Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu City, Sichuan Province, PR China
    • Corresponding Author InformationCorresponding author. #37 Guo Xue Road, Chengdu, China. 610041, Department of Endocrinology and metabolism, West China Hospital. Tel.: +86 28 85422357; fax: +86 28 85423459.

Received 23 February 2010 ,Revised 6 June 2010 ,Accepted 4 July 2010.

References 

  1. Cersosimo E, DeFronzo R. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006;22:423–36.
  2. Aljada A, Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism. 2000;49:147–150
  3. Zeng G, Nystrom F, Ravichandran L, et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101:1539–1545
  4. Muniyappa R, Montagnani M, Koh K, Quon M. Cardiovascular actions of insulin. Endocr Rev. 2007;28:463–491
  5. Itani S, Ruderman N, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 2002;51:2005–2011
  6. Boden G, She P, Mozzoli M, et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes. 2005;54:3458–3465
  7. Bachmann O, Dahl D, Brechtel K, et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes. 2001;50:2579–2584
  8. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 1999;103:253–259
  9. Wang X, Zhang L, Youker K, et al. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes. 2006;55:2301–2310
  10. Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939–1945
  11. Du X, Edelstein D, Obici S, Higham N, Zou M, Brownlee M. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest. 2006;116:1071–1080
  12. Kim F, Tysseling K, Rice J, et al. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol. 2005;25:989–994
  13. Qureshi G, Baig S. Application of high performance liquid chromatography in study of sulphur amino acid metabolism in uremic patients. Biochem Mol Biol Int. 1993;29:359–368
  14. Kaku S, Tanaka M, Muramatsu M, Otomo S. Determination of nitrite by high-performance liquid chromatography system with electrochemical detector: measurement of nitric oxide synthase activity in rat cerebellum cytosol. Biomed Chromatogr 1994;8:14–8.
  15. Steinberg H, Tarshoby M, Monestel R, et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100:1230–1239
  16. Watanabe S, Tagawa T, Yamakawa K, Shimabukuro M, Ueda S. Inhibition of the renin–angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2005;25:2376–2380
  17. Pleiner J, Schaller G, Mittermayer F, Bayerle-Eder M, Roden M, Wolzt M. FFA-induced endothelial dysfunction can be corrected by vitamin C. J Clin Endocrinol Metab. 2002;87:2913–2917
  18. Tripathy D, Mohanty P, Dhindsa S, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 2003;52:2882–2887
  19. Storz P, Döppler H, Wernig A, Pfizenmaier K, Müller G. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Eur J Biochem. 1999;266:17–25
  20. Chavez J, Summers S. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys. 2003;419:101–109
  21. Powell D, Turban S, Gray A, Hajduch E, Hundal H. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J. 2004;382:619–629
  22. Griffin M, Marcucci M, Cline G, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 1999;48:1270–1274
  23. Belfort R, Mandarino L, Kashyap S, et al. Dose–response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 2005;54:1640–1648
  24. Cortright R, Azevedo JJ, Zhou Q, et al. Protein kinase C modulates insulin action in human skeletal muscle. Am J Physiol Endocrinol Metab. 2000;278:E553–E562
  25. Itani S, Zhou Q, Pories W, MacDonald K, Dohm G. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes. 2000;49:1353–1358
  26. Naruse K, Rask-Madsen C, Takahara N, et al. Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes. 2006;55:691–698
  27. Karin M, Yamamoto Y, Wang Q. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov. 2004;3:17–26
  28. Barnes P, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–1071
  29. Luberto C, Yoo D, Suidan H, Bartoli G, Hannun Y. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. J Biol Chem. 2000;275:14760–14766
  30. Kim J, Kim Y, Fillmore J, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest. 2001;108:437–446
  31. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 2001;293:1673–1677
  32. Dichtl W, Nilsson L, Goncalves I, et al. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells. Circ Res. 1999;84:1085–1094
  33. Coudronniere N, Villalba M, Englund N, Altman A. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci USA. 2000;97:3394–3399
  34. Coats A. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(10)00546-2

doi: 10.1016/j.ijcard.2010.07.019

International Journal of Cardiology
Volume 152, Issue 2 , Pages 218-224 , 20 October 2011

Article Tools

* Image Usage & Resolution